Risk score for first-screening of prevalent undiagnosed chronic kidney disease in Peru: the CRONICAS-CKD risk score

Rodrigo M Carrillo-Larco1, J Jaime Miranda1,2, Robert H Gilman1,3,4

  • 1CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Av. Armendariz 497, Miraflores, 18, Lima, Peru.

BMC Nephrology
|December 1, 2017
PubMed

Insights

A new risk score effectively identifies undiagnosed Chronic Kidney Disease (CKD) without lab tests. This tool is crucial for early detection in resource-limited settings, improving patient outcomes.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • Chronic Kidney Disease (CKD) poses a significant global health burden, especially when diagnosed late.
  • Early detection is critical, particularly in resource-limited settings with scarce laboratory facilities.
  • Developing accessible screening tools for undiagnosed CKD is essential.

Purpose of the Study:

  • To develop and validate risk scores for identifying prevalent undiagnosed CKD.
  • To create a comprehensive score and a laboratory-free alternative for diverse settings.
  • To assess the performance of these scores in screening for CKD.

Main Methods:

  • A cross-sectional study utilizing two population-based datasets from Peru for development and validation.
  • Inclusion of clinical variables (age, sex, hypertension, obesity) and laboratory variables (lipids, anemia, glucose).
  • Performance evaluation using ROC curves, sensitivity, specificity, and predictive values.

Main Results:

  • Age, hypertension, and anemia were key predictors of undiagnosed CKD.
  • Both the complete and laboratory-free risk scores demonstrated similar performance (ROC area ~76%).
  • High negative predictive values (99%) indicate strong ability to rule out CKD.

Conclusions:

  • The developed risk scores offer moderate performance for CKD screening.
  • Individuals scoring ≥2 warrant further investigation to exclude CKD.
  • The laboratory-free score is a practical, valuable tool for CKD screening in resource-limited areas.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
248
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
798
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
493
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
356
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
507
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
467